US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

69.80

+2.834.23%

Post-market: 69.900.0975+0.14%16:10 EDT

Volume:858

Turnover:59.77K

Market Cap:698.09K

PE:- -

High:70.05

Open:69.80

Low:69.34

Close:66.97

52wk High:85.03

52wk Low:55.75

Shares:10.00K

Float Shares:10.00K

Volume Ratio:4.75

T/O Rate:8.58%

Dividend:2.08

Dividend Rate:2.97%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Nuvalent Acquisition Fairly Valued, Competing Bid Seen as Unlikely, Wedbush Says

MT Newswires Live

GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

GSK Director Hal Barron Takes Governance Role at Quantinuum

Sector Update: Healthcare

MT Newswires Live

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

Top Midday Stories: GSK to Acquire Nuvalent for $10.6 Billion in Cash; Apple Introduces Siri AI, But EU Launch to be Delayed

MT Newswires Live

Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal -- Barrons.com

GSK's Nuvalent Deal Makes Strategic Sense -- Market Talk

Video: Nuvalent jumps after GSK’s $10.6B takeover deal

Nuvalent Shares Soar Following GSK's Acquisition Announcement

GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs

Nuvalent to Be Acquired by GSK in Cash Deal

How a former lawyer is beating the stock market with these 11 picks

UBS Remains a Hold on GlaxoSmithKline (GSK)

Nuvalent Shares Leap Premarket on Takeover by GSK

GlaxoSmithKline (GSK) Gets a Sell from Barclays

GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent

GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

GSK paying 40% premium to boost the cancer business it previously unwound

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/GSKH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.8025,"timestamp":1789416000000,"preClose":66.9705,"halted":0,"volume":858,"hourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"delay":0,"changeRate":0.042287275740811155,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Not Yet Opened","change":2.832,"latestTime":"09-14 16:00:00 EDT","open":69.8,"high":70.05,"low":69.34,"amount":59772,"amplitude":0.010602,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":66.9705,"nav":66.979706,"aum":669864.039706,"dividendRate":0.029742,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":69.9,"preClose":69.8025,"latestTime":"16:10 EDT","volume":6,"amount":418.815,"timestamp":1789416603786,"change":0.0975,"changeRate":0.001397,"amplitude":0},"volumeRatio":4.745573,"impliedVol":0.1896,"impliedVolPercentile":0.4649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.745573,"shares":10001,"dividePrice":2.0761,"high":70.05,"amplitude":0.010602,"preClose":66.9705,"low":69.34,"week52Low":55.7526,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.8025,"eps":0,"divideRate":0.029742,"volume":858,"delay":0,"ttmEps":0,"open":69.8,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":69.5112,"twentyDayClose":68.9018,"sixtyDayClose":73.2027},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642494730","title":"Nuvalent Acquisition Fairly Valued, Competing Bid Seen as Unlikely, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2642494730","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642494730?lang=en_us&edition=fundamental","pubTime":"2026-06-10 03:19","pubTimestamp":1781032764,"startTime":"0","endTime":"0","summary":"Nuvalent  is fairly valued following GSK's  agreed acquisition of the company, with limited likelihood of a competing bid emerging, Wedbush Securities said in a Tuesday note.The brokerage said most logical strategic acquirers, including Pfizer , Roche and Bristol Myers Squibb , already have meaningful exposure to ALK- and ROS1-positive non-small cell lung cancer markets, making it difficult to justify a higher offer while achieving attractive returns.Wedbush said the deal validates the value of differentiated precision oncology assets with advantages in efficacy, tolerability, resistance mutation coverage and CNS penetration.The investment firm downgraded Nuvalent to neutral from outperform and lowered its price target to $124 from $125, matching the agreed tender offer price from GSK.Shares of Nuvalent rose more than 39% in Tuesday afternoon trading.Price: 123.12, Change: +34.63, Percent Change: +39.13","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4588","BK4007","GSK.UK","BK4585","BK4539","GSK","NUVL","BK4532","GSKH","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642491413","title":"GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642491413","media":"cityam","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642491413?lang=en_us&edition=fundamental","pubTime":"2026-06-10 01:16","pubTimestamp":1781025411,"startTime":"0","endTime":"0","summary":"The rapid scale of modern healthcare data has opened up entirely new avenues  GSK has said agentic AI is already affecting every asset in its pipeline, as pharmaceutical firms race to use the technology to cut the cost and risk of developing new medicines.Speaking at London Tech Week in Tuesday, Eyal Itskovitz, GSK’s director of AI and machine learning, said that the technology has officially become a live operational tool within the pharma giant’s R&D division.“At GSK, all of our assets are currently being impacted by agentic AI, so this is not like a futuristic thing… it’s happening now,” said Itskovitz.The announcement comes on the same morning that GSK shares slipped nearly three per cent on Tuesday, following a blockbuster $10.6bn  cash acquisition of Boston-based biopharma firm Nuvalent.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/07/gsk-getty-57ff73d48ba8f-57ff73d497e8c.webp?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/07/gsk-getty-57ff73d48ba8f-57ff73d497e8c.webp?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/gsk-says-ai-is-reshaping-drug-pipeline-as-nuvalent-deal-hits-shares/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/gsk-says-ai-is-reshaping-drug-pipeline-as-nuvalent-deal-hits-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4007","GSK","AGIX","BK4539","CHAT","NUVL","BK4588","LU1829250122.USD","GSK.UK","BK4532","GSKH","ARTY","BK4139","AIPO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642491677","title":"GSK Director Hal Barron Takes Governance Role at Quantinuum","url":"https://stock-news.laohu8.com/highlight/detail?id=2642491677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642491677?lang=en_us&edition=fundamental","pubTime":"2026-06-10 00:58","pubTimestamp":1781024315,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK has announced that non-executive director Dr Hal Barron has been appointed an independent d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-director-hal-barron-takes-governance-role-at-quantinuum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-director-hal-barron-takes-governance-role-at-quantinuum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","GSK.UK","BK4585","QNT","BK4532","LU1829250122.USD","GSK","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642915974","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2642915974","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642915974?lang=en_us&edition=fundamental","pubTime":"2026-06-10 00:56","pubTimestamp":1781024172,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 1.3% and the State Street Health Care Select Sector SPDR ETF  increasing 0.9%.The iShares Biotechnology ETF  shed 0.3%.In corporate news, GSK  said it signed a definitive agreement Tuesday to acquire Nuvalent  for $10.6 billion in cash. GSK shares rose 0.9%, and Nuvalent surged 39%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","BK4588","XLV","GSK.UK","LU1829250122.USD","FDN","XBI","HCSG","NUVL","BK4539","GSK","LU0029874061.USD","STT","BK4137","BK4139","LU0128526141.USD","BK4007","IBB","BK4585","GSKH","BK4532","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642996314","title":"Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2642996314","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642996314?lang=en_us&edition=fundamental","pubTime":"2026-06-10 00:01","pubTimestamp":1781020895,"startTime":"0","endTime":"0","summary":"The major averages were broadly lower near noon despite oil prices pulling back, as yesterday’s surge in chip stocks failed to build on its momentu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/midday-fly-by-openai-files-for-ipo-gsk-to-acquire-nuvalent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/midday-fly-by-openai-files-for-ipo-gsk-to-acquire-nuvalent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BWET","DRLL","OILK","DIG","GSKH","GSK.UK","SMH","DBO","USE","GUSH","OIH","PSI","DBE","SOXQ","DUG","USO","ERX","IPOS","BNO","SOXL","FTXL","FTXN","GSK","SOXY","SOXS","USD","UGA","OILU","OILT","CHPY","TEKX","USL","WTIU","XES","XSD","DBC","PXE","SMHX","XOP","DRIP","CHPS","USOI","SOXX","PXJ","SSG","VDE","IEO","NUVL","IXC","XLE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642276496","title":"Top Midday Stories: GSK to Acquire Nuvalent for $10.6 Billion in Cash; Apple Introduces Siri AI, But EU Launch to be Delayed","url":"https://stock-news.laohu8.com/highlight/detail?id=2642276496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642276496?lang=en_us&edition=fundamental","pubTime":"2026-06-09 23:37","pubTimestamp":1781019449,"startTime":"0","endTime":"0","summary":"The Dow Jones Industrial Average was up, while the S&P 500 and Nasdaq Composite were down in late-morning trading Tuesday, as a recent surge in chip stocks lost momentum.In company news, GSK (GSK) sai","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B894F039.SGD","LU0080751232.USD","LU2023250504.SGD","LU0211326839.USD","LU1037948897.HKD","LU2089284900.SGD","LU2452424414.USD","LU2462157665.USD","IE000KEQY171.SGD","LU0174119429.USD","IE0003U64NQ7.SGD","SG9999015986.USD","LU0444973449.USD","LU0124676726.USD","LU1066051225.USD","LU1280957306.USD","LU0029864427.USD","LU0345770308.USD","BK4559","LU0511384066.AUD","SG9999014559.SGD","AAPW","LU0265550946.USD","LU2357627491.SGD","LU1244550221.USD","SG9999011175.SGD","IE00B64PRP62.GBP","BK4501","LU2403377893.USD","LU2746668461.USD","SG9999002224.SGD","LU1868836757.USD","LU1301847155.USD","LU1917777945.USD","LU0957808578.USD","LU0353189680.USD","LU2720916845.USD","LU2298321311.HKD","LU0133085943.USD","IE00BGHQF631.EUR","LU1046421795.USD","LU1261432733.SGD","IE0009G5SDU7.USD","LU0957791311.USD","LU1037948541.HKD","LU0345768153.USD","LU0096364046.USD","IE00BDCRKT87.USD","LU2272731782.SGD","LU0354030511.USD","LU0823421333.USD","BK4592","IE00B3S45H60.SGD","LU1732799900.SGD","IE00B19Z3581.USD","SG9999014906.USD","LU1868836591.USD","IE00B3PB1722.GBP","IE00BGHQF748.EUR","IE000Q6AESB8.SGD","LU0211327993.USD","IE00BKVL7J92.USD","LU0943347566.SGD","AVGW","LU1803068623.USD","LU2041044095.USD","IE00BJJMRX11.SGD","LU1267930573.SGD","LU0795875086.SGD","LU0127658192.USD","LU0210533765.USD","LU1496350171.SGD","LU1934455277.USD","LU1551013425.SGD","LU1923623000.USD","IE00BHPRN162.USD","IE000BZT7R73.USD","JPM","BK4543","LU0215105999.USD","LU0949170772.SGD","LU2092937221.SGD","LU1162221912.USD","LU2237957811.SGD","LU2211815571.USD","BK4516","AVL","LU1116320901.HKD","HK0000306685.HKD","LU2237443978.SGD","LU0266013472.USD","LU1791710400.SGD","BK4532","LU0784383803.USD","IE0004091025.USD","IE00BLSP4452.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","IE00BQXX3F31.USD","LU1064131342.USD","SGXZ81514606.USD","LU0820561909.HKD","IE00BMCWC346.EUR","LU2125154935.USD","LU2461242641.AUD","LU0170899867.USD","LU1935042991.SGD","AAPY","LU2100268510.USD","LU2999663052.SGD","APLY","CWII","LU2095319765.USD","LU2637965513.SGD","LU0267386448.USD","IE00BN29S564.USD","CRWV","LU0097036916.USD","LU0689626769.HKD","LU2552382058.USD","LU0314106906.USD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","IE00B5949003.HKD","LU0109392836.USD","AAPB","LU1868837300.USD","LU0444971666.USD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","LU0965509283.SGD","LU1668664300.SGD","BK4539","GSK.UK","IE00B19Z8W00.USD","IE00BKDWB100.SGD","LU2111349929.HKD","LU1582986433.USD","LU1629891620.HKD","LU1623119135.USD","IE000M9KFDE8.USD","IE00BJTD4N35.SGD","BK4566","LU2077746001.SGD","LU1720051108.HKD","LU2083900584.USD","AVGO","LU1202635105.USD","LU2361045086.USD","LU2361044949.HKD","LU2463028550.USD","BK4571","HK0000320264.USD","LU2322448957.HKD","LU0784384876.USD","LU0672654240.SGD","LU1242518857.USD","LU1718418525.SGD","BK4207","IE00B3QW5Z07.USD","IE00BYV24P56.USD","LU1267930730.SGD","LU1894683264.USD","IE0009356076.USD","AVGX","IE00BBT3K403.USD","BK4553","LU1923622614.USD","IE00B1XK9C88.USD","SG9999015358.SGD","LU2087625088.SGD","LU0061474960.USD","LU1934455863.HKD","IE00B19Z9P08.USD","LU2756315318.SGD","LU1992135399.USD","IE000ITXATA3.USD","BK4574","LU0528227936.USD","LU0154236417.USD","LU1119994496.HKD","LU1642822529.SGD","BK4573","IE0004445239.USD","LU0545039389.USD","BK4504","LU1670711123.USD","LU2023250843.SGD","LU2023251221.USD","LU2236285917.USD","SGXZ99366536.SGD","LU0203202063.USD","LU2505996509.AUD","CRWG","LU2237957902.USD","IE00B19Z9505.USD","LU0784385170.HKD","IE00BKPKM429.USD","LU0965509010.AUD","LU0971096721.USD","LU1670710661.SGD","IE00B19Z9Z06.USD","LU0211326755.USD","LU0211331839.USD","LU1069344957.HKD","LU1868836914.USD","LU2237443549.SGD","LU2931357623.SGD","LU0314104364.USD","LU1645745479.HKD","LU1791710582.SGD","IE0034235295.USD","LU2458330243.SGD","IE00BFSS7M15.SGD","LU2420271590.USD","LU2272731600.USD","LU0187121727.USD","LU1400636491.USD","LU1720051017.SGD","LU2168564222.USD","LU2471134952.CNY","LU2286300806.USD","LU2168564065.EUR","LU2433249047.HKD","LU2168564149.EUR","BK4612","LU0225283273.USD","AVGU","LU1582987324.SGD","LU2746668974.SGD","LU2089985449.USD","LU0353189763.USD","LU1244550494.USD","LU0823434740.USD","JPO","SG9999018865.SGD","LU0965508806.USD","BK4534","SG9999002232.USD","LU0072462426.USD","IE0004086264.USD","LU1116320737.USD","LU0979878070.USD","AAPD","BK4170","LU0198837287.USD","LU1829250122.USD","LU1691799644.USD","LU1935042215.USD","LU2237443895.HKD","LU1323610961.USD","LU0251132253.USD","LU0345770993.USD","LU2237443465.HKD","LU2087621335.USD","LU2065171402.SGD","LU1496350502.SGD","LU0345769631.USD","LU2054465674.USD","LU0158827948.USD","LU0011850046.USD","HK0000819398.USD","LU0106261372.USD","LU0708995401.HKD","LU0276348264.USD","LU2360032135.SGD","LU1699723380.USD","BK4579","LU1674673428.USD","BK4575","IE00BSNM7G36.USD","LU2108987350.USD","SG9999014914.USD","AAPL","AAPX","LU0056508442.USD","LU2089283258.USD","IE00BVYPNQ40.USD","LU0784385840.USD","LU0456855351.SGD","LU1823568750.SGD","LU1868837136.USD","LU2592432038.USD","LU0868494708.USD","LU2168563687.JPY","LU0795875169.SGD","LU1804176565.USD","BK4139","LU2361044865.SGD","LU0320765646.SGD","LU2237443622.USD","LU2462591350.SGD","IE00B7KXQ091.USD","LU1791807156.HKD","LU2264538146.SGD","LU0143551892.USD","LU0203201768.USD","HK0000914686.HKD","LU1582986359.USD","LU2552382132.HKD","LU0208291251.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU0203345920.USD","IE0004445015.USD","SGXZ51526630.SGD","LU1861558580.USD","SG9999001440.SGD","LU0823421416.USD","LU0557290698.USD","LU2097344431.USD","HK0000306701.USD","LU2242650005.HKD","LU2360108059.USD","LU1989764664.SGD","LU1989764748.USD","BK4585","LU1670627923.USD","SG9999004303.SGD","LU0234572021.USD","LU0210536198.USD","LU0320765489.SGD","LU2543165471.USD","LU2417539215.USD","LU0820561818.USD","LU1861559042.SGD","LU1153585028.USD","LU0788109477.HKD","LU0310800379.SGD","LU3102509885.SGD","BK4576","LU1712237335.SGD","LU2237443382.USD","LU1989772923.USD","LU0354030438.USD","IE00BVYPNV92.GBP","IE0005OL40V9.USD","IE00B4YYXB79.USD","LU2242649171.HKD","LU1066051498.USD","IE0000B7K699.USD","SG9999015952.SGD","LU2125909593.SGD","LU0965509101.SGD","LU1815333072.USD","LU0786609619.USD","LU1914381329.SGD","LU0211328371.USD","LU0053666078.USD","LU1894683348.USD","GSKH","LU2133065610.SGD","LU0316494557.USD","LU0787776722.HKD","SG9999014575.USD","LU0689472784.USD","AAPU","LU1951200564.SGD","LU1992135472.HKD","LU2750360997.AUD","APO","LU1400636657.SGD","IE00BFSS8Q28.SGD","LU1506573853.SGD","BK4515","SG9999018857.SGD","LU0256863811.USD","SG9999014542.SGD","LU1084165304.USD","CORD","IE00BZ1G4Q59.USD","LU2471134796.USD","LU1670628061.USD","LU0861579265.USD","LU0048584097.USD","BK4141","LU0061475181.USD","LU1582987597.SGD","LU0726765562.USD","HK0000532082.HKD","IE000SO60NU8.SGD","LU0553294199.USD","LU1206713676.USD","NUVL","LU2247934214.USD","IE00B19Z3B42.SGD","LU0081259029.USD","LU0238689110.USD","LU0494093205.USD","IE00BMPRXN33.USD","IE00BMPRXQ63.HKD","LU0265550359.USD","LU2357305700.SGD","LU2764262908.HKD","SG9999017495.SGD","LU1267930490.SGD","BK4533","BX","LU2750360641.GBP","LU1316542783.SGD","LU2430703095.HKD","IE00B775SV38.USD","LU0157215616.USD","CWVX","LU1670711040.USD","IE00BJTD4V19.USD","IE00B4JS1V06.HKD","LU1291159041.SGD","IE000WAW04H5.SGD","LU2602419157.SGD","LU2381873111.SGD","JPX","IE0002270589.USD","LU2764263203.CNY","LU0882574139.USD","LU2092627202.USD","LU0256863902.USD","LU0149725797.USD","LU0417517546.SGD","LU1935043536.SGD","LU0823434583.USD","LU2430703178.SGD","LU0106831901.USD","LU0642271901.SGD","LU2065169927.USD","LU1988902786.USD","LU1363072403.SGD","BK4135","IE000F7OJYX1.SGD","LU0070217475.USD","LU2265009873.SGD","LU2210150020.SGD","LU1732800096.USD","SG9999001424.SGD","IE00BFXG1179.USD","SG9999015978.USD","LU0310799852.SGD","LU1989771016.USD","IE000YTNTUN2.SGD","LU1852331112.SGD","LU0719512351.SGD","LU1145028129.USD","LU0496365809.HKD","LU0724617625.USD","SG9999015945.SGD","LU0308772762.SGD","BK4527","LU0061474705.USD","LU0949170426.SGD","GB00BDT5M118.USD","SG9999014567.USD","LU0323591593.USD","LU0203347892.USD","LU2250418816.HKD","LU0079474960.USD","LU0128525929.USD","BK4551","LU2097344357.USD","LU0096362180.USD","LU1127390331.HKD","IE0034235188.USD","LU0472753341.HKD","SG9999000418.SGD","LU1674673691.USD","LU0082616367.USD","LU1935043023.USD","LU2272731865.HKD","SGXZ23171101.USD","LU0820562030.AUD","BK4007","LU1235294995.USD","IE00BZ9MQY76.HKD","LU1989772840.SGD","AVGG","LU0077335932.USD","LU2473716301.USD","LU1400636574.HKD","LU2347655156.SGD","IE00BVYPNP33.GBP","LU1032466523.USD","LU2360106780.USD","BK4605","LU2211814178.USD","LU1242518931.SGD","LU2244417387.USD","SG9999015341.SGD","LU0006061336.USD","LU2279689827.SGD","LU0683600562.USD","LU2462591277.SGD","LU1814569148.SGD","IE00BWXC8680.SGD","IE00B19Z8X17.USD","LU0006306889.USD","LU2106854487.HKD","LU2322448791.USD","LU1934455194.USD","LU0912757837.SGD","IE00BYXW3230.USD","LU1571399168.USD","BK4550","LU1206712785.SGD","SG9999003800.SGD","LU1035775433.USD","LU1366333091.USD","LU0964807845.USD","LU2860962120.EUR","LU0661504455.SGD","LU2471134879.HKD","CRWU","IE00BQXX3D17.EUR","LU0069063385.USD","LU2237438978.USD","LU0320765059.SGD","LU1066053197.SGD","IE00BJJMRY28.SGD","LU0070302665.USD","LU0109391861.USD","LU0210528500.USD","LU2065170008.USD","LU0976567544.SGD","IE000W1ABFV2.USD","IE00BLSP4239.USD","IE00BGHQDM52.EUR","LU0466842654.USD","LU2063271972.USD","LU2347655073.USD","LU2213496289.HKD","IE00BMPRXR70.SGD","LU1066051811.HKD","LU0985320562.USD","LU2047632596.USD","LU2125909247.SGD","JPMO","LU0889565833.HKD","MACW.SI","LU2028103732.USD","LU1815336760.USD","BK4554","BK4588","BK4507","BK4512","LU0345769128.USD","BK4598","GSK","IE00BVYPNW00.USD","LU0640476718.USD","LU0289961442.SGD","LU2191332357.HKD","LU2168564495.EUR","LU0738911758.USD","LU1670756490.USD","LU2954938101.SGD","AVS","LU2505996681.GBP","LU2756315664.SGD","LU1366192091.USD","LU2552382215.SGD","IE00BQXX3C00.GBP","LU0057025933.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU0289739343.SGD","LU0708994859.HKD","BK4581","LU2210149790.SGD","LU2355687059.USD","IE0034235303.USD","LU2430703251.USD","LU2764263039.SGD","LU1839511570.USD","LU2125154778.USD","LU0274383776.USD","LU1935042488.USD","LU2023250330.USD","IE00B3SWFQ91.USD","IE00B775H168.HKD","BK4505","LU1551013342.USD","SGXZ31699556.SGD","BK4184","LU0234570918.USD","IE00B42XCP33.USD","LU2487616109.SGD","SG9999014880.SGD","LU0158827781.USD","LU1670710588.SGD","LU1778281490.HKD","LU2065171311.SGD","LU2896262040.SGD","IE00BDRTCR15.USD","LU2271345857.HKD","LU1244550577.SGD","HK0000914660.USD","LU1003077747.HKD","LU0476273544.USD","BK4116","LU1232071149.USD","LU0942090050.USD","LU1951198990.SGD","LU2471134523.USD","LU0345768740.USD","LU0859254822.USD","LU2456880835.USD","LU2458330169.SGD","LU1548497426.USD","LU0348723411.USD","IE00BJLML261.HKD","LU1803068979.SGD","HK0000320223.HKD","LU2092937148.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642493129","title":"Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2642493129","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642493129?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:00","pubTimestamp":1781013600,"startTime":"0","endTime":"0","summary":"Nuvalent stock was soaring Tuesday after British pharmaceutical company GSK said it had agreed to buy the cancer-drug developer for $10.6 billion.Shares of Nuvalent jumped 39% to $122.90. GSK's American depositary receipts were flat at $50.65.GSK is making a tender offer for Nuvalent at $124 a share in cash, a 40% premium to where Nuvalent stock traded as of Monday's closing bell. The biotech has two experimental lung-cancer drugs in late development, zidesamtinib and neladalkib.The deal may rattle GSK shareholders, given it would be the company's biggest acquisition in eight years.GSK swapped its oncology business for Novartis' vaccines division in a 2014 deal, but is now trying to strengthen its pipeline of cancer drugs.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4585","BK4007","NUVL","BK4139","GSKH","LU1829250122.USD","GSK","BK4539","BK4588","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642493507","title":"GSK's Nuvalent Deal Makes Strategic Sense -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642493507","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642493507?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:49","pubTimestamp":1781012940,"startTime":"0","endTime":"0","summary":"1349 GMT - GSK's $10.6 billion acquisition of Nuvalent seems to make strategic sense, even if it is bigger than the deals the U.K. drugmaker has targeted in the past, Bernstein analysts say in a research note. The company expects Nuvalent to be different from its last big oncology acquisition, a $5 billion deal for Tesaro back in 2019, the analysts say. The Tesaro deal hasn't created value, but GSK will take measures to mitigate the dilution on profitability from the deal this time around, according to Bernstein. GSK hopes its broad geographic reach and the better tolerability profile of Nuvalent's lung-cancer drugs compared to available therapies can make the deal work, the analysts say. Shares in GSK fall 1.3%. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4532","BK4585","BK4588","LU1829250122.USD","BK4539","GSKH","BK4139","GSK","NUVL","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642498196","title":"Video: Nuvalent jumps after GSK’s $10.6B takeover deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2642498196","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642498196?lang=en_us&edition=fundamental","pubTime":"2026-06-09 21:16","pubTimestamp":1781010970,"startTime":"0","endTime":"0","summary":"The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how the markets will open, which stocks will...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/video-nuvalent-jumps-after-gsks-10-6b-takeover-deal-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/video-nuvalent-jumps-after-gsks-10-6b-takeover-deal-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","LU1829250122.USD","BK4007","BK4539","BK4585","GSK","GSKH","NUVL","BK4139","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171432341","title":"Nuvalent Shares Soar Following GSK's Acquisition Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1171432341","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171432341?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:20","pubTimestamp":1781007636,"startTime":"0","endTime":"0","summary":"Shares of the American pharmaceutical company Nuvalent, Inc. surged nearly 39% after British biopharmaceutical firm GlaxoSmithKline PLC announced its acquisition of the company for $10.6 billion.This...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","GSK.UK","BK4585","NUVL","BK4532","BK4539","BK4139","LU1829250122.USD","GSK","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145540131","title":"GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1145540131","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145540131?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:03","pubTimestamp":1781006584,"startTime":"0","endTime":"0","summary":"British pharmaceutical giant GlaxoSmithKline PLC announced on Tuesday that it has reached an agreement to acquire U.S. biotech firm Nuvalent, Inc. for $10.6 billion. The news sent Nuvalent, Inc....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","GSK.UK","NUVL","BK4532","LU1829250122.USD","GSK","BK4585","BK4139","BK4588","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642462140","title":"Nuvalent to Be Acquired by GSK in Cash Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2642462140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642462140?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:29","pubTimestamp":1781004551,"startTime":"0","endTime":"0","summary":"Nuvalent ( ($NUVL) ) has shared an update. On 9 June 2026, Nuvalent entered into a merger agreement under which GlaxoSmithKline will launch a tende...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nuvalent-to-be-acquired-by-gsk-in-cash-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nuvalent-to-be-acquired-by-gsk-in-cash-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUVL","LU1829250122.USD","BK4007","BK4588","BK4139","BK4585","GSK.UK","GSKH","BK4532","BK4539","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642464581","title":"How a former lawyer is beating the stock market with these 11 picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2642464581","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642464581?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:59","pubTimestamp":1781002740,"startTime":"0","endTime":"0","summary":"Alphabet and Mastercard are top holdings of this outperforming fund. Alphabet has a lot of winning businesses, says fund manager Tom Winmill.\"What we like to see in the numbers are a lot of free cash flow and then the ability of that company to reinvest free cash flow in order to get the compounding effect, and Alphabet has the ability to do so,\" he said, adding it has an \"unassailable advantage in growth.\" He favors Mastercard for many of the same reasons.\"They were basically investing in a business that was slowing down by buying back their stock, taking on debt. Those are bad signs,\" he said. \"And then they're going to lower-margin markets like expanding into Central and South America.\". \"They're growing, and they have a dynamic approach to pricing in the market,\" along with a solid history and focused management, he said of the insurer.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUVL","GSK","MSFL","APLZ","LU1988902786.USD","MSFD","USJW.SI","JPO","APLX","GSKH","JPMO","GOU","MSFT","MSFW","BULZ","GOOP","BRKC","APLD","PGR","TSLA","WSM","NVDA","GOOX","AAPL","MSFY","MTN","BRKU","AZO","MA","MSFO","AMZN","MSFU","MAGY","LU0985489474.SGD","MSFX","GGLL","GOOW","JPX","GOOGL","BRKW","GOOG","BRK.B","BRKD","GOOY","YMAG","GSK.UK","GGLS","META","LRCX","LRCU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469527","title":"UBS Remains a Hold on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469527","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642469527?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:45","pubTimestamp":1780998339,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of £19.40. According to TipRanks, Weston is a 4...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-remains-a-hold-on-glaxosmithkline-gsk-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4532","LU1863844665.USD","LU1863844749.USD","IE0034235071.USD","BK4007","GSKH","GSK.UK","UBS","LU1829250122.USD","BK4118","BK4585","LU3187612489.SGD","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642664504","title":"Nuvalent Shares Leap Premarket on Takeover by GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2642664504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642664504?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:45","pubTimestamp":1780998300,"startTime":"0","endTime":"0","summary":"Shares of Nuvalent surged in premarket trading Tuesday after the clinical-stage biopharmaceutical company agreed to be acquired by U.K. pharmaceutical company GSK for $10.6 billion.GSK is paying $124 a share in cash for Nuvalent, a 40% premium to Monday's closing price of $88.49 for the Cambridge, Mass., company.The deal is slated to close in the third quarter.Nuvalent shares were recently up more than 38% to $122.51 in premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4539","NUVL","BK4139","BK4532","BK4585","BK4007","LU1829250122.USD","GSK","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642466901","title":"GlaxoSmithKline (GSK) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2642466901","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642466901?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:36","pubTimestamp":1780997770,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Sell rating on GlaxoSmithKline today and set a price target of £18.00. According to TipRanks, Gordon...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","BK4585","GSK","GSKH","LU1829250122.USD","CFA","BK4588","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164747521","title":"GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=1164747521","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164747521?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:31","pubTimestamp":1780997497,"startTime":"0","endTime":"0","summary":"The British pharmaceutical giant GlaxoSmithKline PLC has finalized an agreement to acquire the US-based biopharmaceutical company Nuvalent, Inc. for a total of $10.6 billion, aiming to significantly...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4532","GSKH","BK4539","GSK.UK","LU1829250122.USD","NUVL","BK4585","BK4007","BK4139","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642465642","title":"GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642465642","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642465642?lang=en_us&edition=fundamental","pubTime":"2026-06-09 17:07","pubTimestamp":1780996020,"startTime":"0","endTime":"0","summary":"0906 GMT - The initial market reaction to GSK's $10.6 billion acquisition of cancer specialist Nuvalent points to some trepidation among investors about the size of the deal, AJ Bell's Russ Mould says. Nuvalent is the U.K. drugmaker's biggest acquisition in years and fits with its goal of turning oncology into a key growth engine for the group, Mould says. \"GSK is paying a hefty premium to get the deal over the line and the two big lung cancer products flagged by [GSK CEO Luke] Miels in heralding the takeover still await regulatory approval,\" Mould says. \"In rolling the dice on such a big transaction, he is undoubtedly taking a risk.\" GSK shares fall 3.3%. Nuvalent jumps 38% in U.S. premarket trading. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4588","GSK","GSKH","BK4139","BK4532","NUVL","BK4007","BK4585","LU1829250122.USD","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463396","title":"Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642463396?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:39","pubTimestamp":1780994340,"startTime":"0","endTime":"0","summary":"Under a new CEO, GSK makes a big bet on cancer drugs. GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4585","LU0070302665.USD","GSK","BK4007","NUVL","BK4539","BK4532","GSKH","IE00BJJMRZ35.SGD","LU1829250122.USD","BK4588","NVS","LU0208291251.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU0211331839.USD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4578","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450055","title":"GSK paying 40% premium to boost the cancer business it previously unwound","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450055","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450055?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:54","pubTimestamp":1780991640,"startTime":"0","endTime":"0","summary":"This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1829250122.USD","GSK.UK","BK4588","GSKH","BK4007","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}